Pharmacist Association Warns of Drug Shortages After Easter

Germany's pharmacist association, ABDA (Bundesvereinigung Deutscher Apothekerverbände), has expressed concern over a potential drug shortage that could worsen after Easter 2023. The primary reason cited is the expiration of the SARS-CoV-2-Arzneimittelversorgungsverordnung on April 7, a regulation that had granted pharmacists broad flexibility to ensure drug supplies amid delivery challenges.

A key issue identified by ABDA is the creation of a regulatory gap following the expiration of these measures. This gap, the association argues, poses a significant threat to the reliability of drug supply within Germany. The organization has stated its preparation for various political protests aimed at addressing the situation, highlighting that delivery problems for essential medicines are already a daily occurrence for pharmacies and the issue is escalating.

The association has also voiced criticism regarding the parliament's actions, suggesting that not enough has been done to avert the impending crisis. While measures to mitigate supply difficulties have been extended, ABDA continues to call for further actions to ensure a long-term, stable supply of pharmaceuticals, particularly addressing issues with generic drugs.

The period following Easter may present substantial challenges to Germany's healthcare system if legislative gaps are not promptly addressed. ABDA emphasizes the critical role pharmacies play in guaranteeing medication access for the public under all circumstances.